Kellie Lerner has nearly two decades of experience litigating high stakes antitrust disputes on behalf of both plaintiffs and defendants in federal courts throughout the country. Ms. Lerner currently serves in leadership positions in BCBSM, Inc. v. Vyera Pharmaceuticals, LLC, et al., In re Merck Mumps Vaccine Antitrust Litig., In re Hard Disk Drive Suspension Assemblies Antitrust Litig., and Sterk, et al. v. The Bank of Nova Scotia, et al. She previously represented a publicly traded corporation where she successfully obtained a complete dismissal of a federal and multi-state antitrust class action filed against her client. She also counsels generic pharmaceutical, alternative energy and entertainment companies on competition issues. Ms. Lerner is also principally responsible for identifying and initiating new antitrust actions at the firm. In this capacity, she has initiated the first antitrust class action lawsuits in the country in dozens of actions that have ultimately resulted in billions of dollars in recoveries for victims of anti-competitive conduct.
In 2020, Ms. Lerner was selected by the New York Law Journal for its “Distinguished Leader” award, which honors attorneys in leadership positions who achieved impressive and positive results over the past year. In 2019, The National Law Journal named her as one of the "Elite Women of the Plaintiff's Bar," and the New York Law Journal recognized her as a "New York Trailblazer." Ms. Lerner has also been recognized for the last four consecutive years as a leading practitioner in Antitrust law in the Chambers USA Guide, in which she has been praised by her peers for her ability to "get large teams of people to work effectively together," as well as for being a “zealous advocate.” Also according to Chambers, “She is a brilliant tactician and a fierce litigator. She does this while maintaining a cordial relationship both with other plaintiffs' counsel and with defense counsel.” In recent years, Ms. Lerner has also been selected by Benchmark Litigation as a “Litigation Star” (2022 Edition), by The National Law Journal as an "Antitrust and M&A Trailblazer" (2016), by New York Law Journal as one of 44 competition lawyers under 40 “who have made their mark on the New York legal community,” and by Law360 in its “Rising Star” list of five competition lawyers under the age of 40 to watch. The Legal 500 USA has also praised Ms. Lerner for her “superior intellect, determination and political savvy in getting the job done.” In 2018, she was the recipient of Inside Counsel's "National Women in Law" Award. A frequent author and lecturer, Ms. Lerner is a recognized voice on all issues of antitrust law and her opinions have been quoted in The Washington Post, Bloomberg Businessweek, Yahoo News, and CBS MoneyWatch, among other publications.
Ms. Lerner is a member of the Executive Committee and Chair of Diversity for the Antitrust Section of the New York State Bar Association, a member of the Advisory Board of the Institute of Consumer Antitrust Studies of the Loyola University Chicago School of Law, Co-Chair of the National Association of Women Lawyers' Litigation Affinity Group, Executive Committee Member and Secretary of The Committee to Support the Antitrust Laws (COSAL), and an Editor of the ABA Antitrust magazine.
Ms. Lerner co-founded Roseann’s Gift, an organization named for her late mother and dedicated to raising research funding to cure lung cancer. The organization is funding lung cancer research at Weill Medical College of Cornell University. She is a member of the Tri-State Area Advisory Board of Jumpstart, which works to provide equal access to literacy education for preschool children in under-resourced communities and was previously a member of the Board of Directors for the Jewish Community Project Downtown, an organization that was formed in the wake of the September 11th attacks to revitalize the Jewish community in lower Manhattan. She currently provides pro bono assistance to KIND (Kids In Need of Defense) and has previously provided assistance to the Transgender Legal Defense and Education Fund, AARP and the Lawyers Committee for Civil Rights Under the Law.
BCBSM, Inc. v. Vyera Pharmaceuticals, LLC, et al.: Interim Lead Counsel for indirect purchasers alleging that Martin Shkreli and his former companies illegally monopolized the market for the life-saving drug Daraprim.
Anastasio, et al v. Total Gas & Power North America, Inc.: Involving an alleged unlawful trading scheme to manipulate the index settlement prices of natural gas as well as the prices of physical natural gas and natural gas futures contracts.
Insulate SB, Inc. v. Advanced Finishing Systems, Inc., Lead counsel for fluid-handling equipment manufacturer Graco Inc. in putative nationwide antitrust class action alleging unlawful business acquisitions and boycott, exclusive-dealing, and monopolization conspiracies. We obtained the dismissal of all claims with prejudice, 2014 U.S. Dist. LEXIS 31188 (D. Minn. Mar. 11, 2014), and we represented Graco in the appeal, where the judgment was affirmed. __ F.3d __, 2015 U.S. App. LEXIS 14233 (8th Cir. Aug. 13, 2015).
In re Merck Mumps Vaccine Antitrust Litigation: Involving an alleged decade-long scheme to falsify efficacy data and maintain a monopoly in the market for the mumps vaccine.
In re Flat Glass II Litigation: Over $22 million settlement on behalf of direct purchasers of construction flat glass. (Prior to joining Robins Kaplan LLP)
In re Puerto Rican Cabotage Antitrust Litigation: $52 million settlement for an alleged conspiracy to fix the prices of ocean freight services between the continental United States and Puerto Rico. (Prior to joining Robins Kaplan LLP)
In re Abbott Labs Norvis Antitrust Litigation: $10 million settlement stemming from Abbott Laboratories’ price increase of Norvir, which provides for a payment to non-profit organizations serving individuals with HIV. (Prior to joining Robins Kaplan LLP)
In re TriCor Indirect Purchaser Antitrust Litigation: $65.7 million settlement for claims that the price charged for Tricor was inflated because of anticompetitive conduct, including product hopping in order to unlawfully suppress generic competition. (Prior to joining Robins Kaplan LLP)
- Roseanne’s Gift, Co-Founder
- Jumpstart, Advisory Board
- KIND (Kids In Need of Defense), Volunteer Lawyer
- Jewish Community Project, Board Member (2014-2018)
- The Deal, "Cargill Ruffles Poultry Consolidation Feathers in Washington," (October 21, 2021)
- Law360, "Merging Cos. Incorporating FTC's 'At Own Risk' Warnings," (September 14, 2021)
- Augusta Free Press, "Lambda Legal sues DOC on behalf of incarcerated trans man denied care," (August 26, 2021)
- Metro Weekly, "Transgender prisoner sues Virginia Department of Corrections over denial of surgery," (August 26, 2021)
- Law360, "Biden's Antitrust Policies Won't Depart Entirely From Trump's," (August 23, 2021)
- Yahoo! Finance, "How new antitrust bills may disrupt big tech," (June 14, 2021)
- Global Competition Review, “First class action filed over Shkreli’s price-hike of Daraprim,” (March 5, 2021)
- Reuters, "Shkreli, former company face insurer class action over price hike,”(March 4, 2021)
- Minneapolis Star-Tribune, “Blue Cross of Minnesota lawsuit takes aim at ‘Pharma Bro’,” (March 4, 2021)
- New York Law Journal, “ ‘Pharma Bro’ Martin Shkreli, Vyera Targeted in Private Class Action Stemming From Drug Price Hike,” (March 4, 2021)
- Law360, “ ‘Pharma Bro’ Shkreli Hit With 1st Private Antitrust Suit,” (March 4, 2021)
- Managed Healthcare Executive, “Minnesota Blues plan sues Shkreli, others for illegal pricing of Daraprim,” (March 4, 2021)
- New York Law Journal, “Amidst Filing Blitz, MDL Sought in Wells Fargo Actions” (August 10, 2017)
- Law360, “Total SA Seeks Exit From Traders' Market Manipulation Suit” (September 26, 2016)
- Bloomberg BNA, “Total Faces $213.6 Million Penalty in U.S. Gas Rigging Case” (April 29, 2016)
- Global Competition Review, “Louisiana Representative proposes Illinois Brick repealer” (March 15, 2016)
- Law360, “Competition Cases to Watch in 2016,” (December 24, 2015)
- Inside Health Policy, "'Shared' REMS Policy Continues To Draw Brand, Generic Makers' Concerns" (July 16, 2015)
- Law 360 “Contact Lens Cos. Face Collusion Suit From Indirect Buyers” (March 9, 2015)
- Inside Counsel, “Another Lawsuit Filed in Response to Alleged Contact Lens Price Conspiracy” (March 12, 2015)
- Law360, “Competition Legislation and Regulation to Watch in 2015” (January 2, 2015)
- The Wall Street Journal, “Did Merck Unfairly Monopolize the Market for a Mumps Vaccine?”
(September 10, 2014)
- Reuters Legal, “Merck Must Face Antitrust Suits Over Mumps Vaccine” (September 9, 2014)
- FiercePharma, “Judge: Merck Must Fight Claims That it Lied About Mumps Vaccine Benefits” (September 9, 2014)
- FierceVaccines, “Lawsuits Claiming Merck Lied About Mumps Vaccine Efficacy Headed to Trial” (September 9, 2014)
- PharmaManufacturing.com, “Merck Virologists Claim Merck Lied About Mumps Vax Efficacy, Trial Moves Forward” (September 9, 2014)
- Drug Discovery News, “Antitrust and Some Other Mumps Claims Against Merck Proceed” (September 8, 2014)
- The Legal Intelligencer, “Qui Tam, Class Action Cases Against Merck Proceed” (September 8, 2014)
- The Inquisitr, “Lawsuits Allege Merck Lied About MMR Efficacy, Motions To Dismiss Denied” (September 7, 2014)
- CNN iReport, “Merck's Motion to Dismiss Denied in Mumps Whistleblower Suits” (September 6, 2014)
- Law360, “Antitrust, FCA Claims on Merck Mumps Vaccine to Advance” (September 5, 2014)
- Reuters Legal, “Antitrust litigation seen emerging from forex manipulation probes” (October 31, 2013)
- Reuters Legal, “Class actions aim to apply antitrust laws to oil pricing” (June 26, 2013)
- Bloomberg, “Apple’s Cue Is Key to Defense of E-Book Price-Fixing Case” (June 13, 2013)
- Law360, “Robins Kaplan Adds Ace Antitrust Negotiators from Labaton” (January 30, 2013)
- Forbes, "'All Natural Turkeys.' One Huge Reason to Buy Them" (November 19, 2012)
- Yahoo News, “Lawsuits Slams ‘Natural’ Claims from OJ to Chips” (May 31, 2012)
- PC World Business, “DOJ’s Antitrust Case May Have Huge Implications for Publishing” (April 18, 2012)
- The Washington Post, “Winners and Losers from DOJ Suit Against Apple, Publishers” (April 11, 2012)
- Business Insider, “Vita Coco Will Pay $10 Million to Settle Suit Over ‘Super Hydrating’ Coconut Water” (February 10, 2012)
- CBS Money Watch, "Vita Coco Will Pay $10 Million to Settle Suit Over 'Super Hydrating' Coconut Water" (February 10, 2012)
- Associated Press via Yahoo! News, “Vita Coco Settles Lawsuit on Nutrition Contents” (February 8, 2012)
- Law360, “Coconut Water Maker Reaches $10M Deal Over Mislabeling” (February 8, 2012)
- Bloomberg Businessweek, "Vita Coco Settles Lawsuit on Nutrition Contents" (February 8, 2012)
- Law360, “ATM Users Swipe at Banks, Cards Cos. in Antitrust Suit” (November 19, 2011)
- Law360, “Lensmaker Transitions Can’t Shake Antitrust MDL” (November 1, 2011)
- BNA Banking Report, “Suit Charges Price-Fixing on ATM Fees by Visa, Mastercard, and Member Banks” (October 20, 2011)
- Law360, “Labation Sues Auto Parts Cos. on Heels of DOJ Fine” (October 6, 2011)
- Law360, “Oil Traders Face Investor Class Action After CFTC Suit” (May 31, 2011)
- Reuters, “Investor Sues Oil Traders Over Alleged Manipulation” (May 26, 2011)
- Law360, “Rising Star: Labaton Sucharow's Kellie Lerner” (March 14, 2011)
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.